Improving efficiencies and uncomplicating processes are critical to the future success of NHS Trusts across the country. The ...

Whether stemming from early childhood adversity, combat exposure, or interpersonal abuse, trauma leaves long-term imprints on ...

Taiho Pharmaceutical has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy ...

Also cited in the complaint (PDF) are FDA Commissioner Marty Makary, NIH Director Jay Bhattacharya, who appeared alongside ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

Medistry LLC is the internet registry operator of the .med top level domain (TLD). Currently in a period of pre-registration ...

A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

The second annual HLTH Europe conference brought together health leaders, start-ups, investors, and developers from across the globe for a mid-year pulse check on where healthcare innovation stands ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply held assumptions” about how the FDA ought to do its work. “We ...

The biotech industry in the US is facing a period of unprecedented uncertainty under the Trump administration, but accountancy firm EY (Ernst & Young) recommends that companies "focus on ...

Hopes rise for a new treatment option for people living with lupus, after UCB and Biogen reveal phase 3 data with their anti-CD40L antibody DZP.